| Infection of a human hepatoma cell line by hepatitis B virus P Gripon, S Rumin, S Urban, J Le Seyec, D Glaise, I Cannie, C Guyomard, ... Proceedings of the National Academy of Sciences 99 (24), 15655-15660, 2002 | 1471 | 2002 |
| Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes YI Ni, FA Lempp, S Mehrle, S Nkongolo, C Kaufman, M Fälth, J Stindt, ... Gastroenterology 146 (4), 1070-1083. e6, 2014 | 817 | 2014 |
| Hepatitis B virus infection initiates with a large surface protein–dependent binding to heparan sulfate proteoglycans A Schulze, P Gripon, S Urban Hepatology 46 (6), 1759-1768, 2007 | 552 | 2007 |
| Prevention of hepatitis B virus infection in vivo by entry inhibitors derived from the large envelope protein J Petersen, M Dandri, W Mier, M Lütgehetmann, T Volz, F Von Weizsäcker, ... Nature biotechnology 26 (3), 335-341, 2008 | 447 | 2008 |
| Treatment of chronic hepatitis D with the entry inhibitor myrcludex B: First results of a phase Ib/IIa study P Bogomolov, A Alexandrov, N Voronkova, M Macievich, K Kokina, ... Journal of hepatology 65 (3), 490-498, 2016 | 437 | 2016 |
| Efficient inhibition of hepatitis B virus infection by acylated peptides derived from the large viral surface protein P Gripon, I Cannie, S Urban Journal of virology 79 (3), 1613-1622, 2005 | 431 | 2005 |
| Viral and cellular determinants involved in hepadnaviral entry D Glebe, S Urban World journal of gastroenterology: WJG 13 (1), 22, 2007 | 425 | 2007 |
| The entry inhibitor Myrcludex-B efficiently blocks intrahepatic virus spreading in humanized mice previously infected with hepatitis B virus T Volz, L Allweiss, MB ḾBarek, M Warlich, AW Lohse, JM Pollok, ... Journal of hepatology 58 (5), 861-867, 2013 | 400 | 2013 |
| Strategies to inhibit entry of HBV and HDV into hepatocytes S Urban, R Bartenschlager, R Kubitz, F Zoulim Gastroenterology 147 (1), 48-64, 2014 | 380 | 2014 |
| Strategies to inhibit entry of HBV and HDV into hepatocytes S Urban, R Bartenschlager, R Kubitz, F Zoulim Gastroenterology 147 (1), 48-64, 2014 | 380 | 2014 |
| HBV DNA integration: molecular mechanisms and clinical implications T Tu, MA Budzinska, NA Shackel, S Urban Viruses 9 (4), 75, 2017 | 359 | 2017 |
| Present and future therapies of hepatitis B: from discovery to cure TJ Liang, TM Block, BJ McMahon, MG Ghany, S Urban, JT Guo, ... Hepatology 62 (6), 1893-1908, 2015 | 340 | 2015 |
| Mapping of the hepatitis B virus attachment site by use of infection-inhibiting preS1 lipopeptides and tupaia hepatocytes D Glebe, S Urban, EV Knoop, N Çaǧ, P Krass, S Grün, A Bulavaite, ... Gastroenterology 129 (1), 234-245, 2005 | 316 | 2005 |
| Cyclosporin A inhibits hepatitis B and hepatitis D virus entry by cyclophilin-independent interference with the NTCP receptor S Nkongolo, Y Ni, FA Lempp, C Kaufman, T Lindner, K Esser-Nobis, ... Journal of hepatology 60 (4), 723-731, 2014 | 281 | 2014 |
| Fine mapping of pre-S sequence requirements for hepatitis B virus large envelope protein-mediated receptor interaction A Schulze, A Schieck, Y Ni, W Mier, S Urban Journal of virology 84 (4), 1989-2000, 2010 | 270 | 2010 |
| Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation M Lütgehetmann, LV Mancke, T Volz, M Helbig, L Allweiss, ... Hepatology 55 (3), 685-694, 2012 | 244 | 2012 |
| First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B A Blank, C Markert, N Hohmann, A Carls, G Mikus, T Lehr, A Alexandrov, ... Journal of hepatology 65 (3), 483-489, 2016 | 224 | 2016 |
| Characterization of a hepatitis B and hepatitis delta virus receptor binding site M Engelke, K Mills, S Seitz, P Simon, P Gripon, M Schnölzer, S Urban Hepatology 43 (4), 750-760, 2006 | 210 | 2006 |
| The replication cycle of hepatitis B virus S Urban, A Schulze, M Dandri, J Petersen Journal of hepatology 52 (2), 282-284, 2010 | 201 | 2010 |
| T cells redirected against hepatitis B virus surface proteins eliminate infected hepatocytes F Bohne, M Chmielewski, G Ebert, K Wiegmann, T Kürschner, A Schulze, ... Gastroenterology 134 (1), 239-247, 2008 | 193 | 2008 |
Florian A LemppVir BiotechnologyBestätigte E-Mail-Adresse bei vir.bio
